Diana Lim

705 total citations
19 papers, 331 citations indexed

About

Diana Lim is a scholar working on Molecular Biology, Reproductive Medicine and Cancer Research. According to data from OpenAlex, Diana Lim has authored 19 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Reproductive Medicine and 5 papers in Cancer Research. Recurrent topics in Diana Lim's work include Ovarian cancer diagnosis and treatment (7 papers), Cancer Genomics and Diagnostics (4 papers) and Hepatitis B Virus Studies (3 papers). Diana Lim is often cited by papers focused on Ovarian cancer diagnosis and treatment (7 papers), Cancer Genomics and Diagnostics (4 papers) and Hepatitis B Virus Studies (3 papers). Diana Lim collaborates with scholars based in Singapore, Australia and Taiwan. Diana Lim's co-authors include Jeffrey Low, Tze Ping Loh, Nicholas R. Y. Ho, Joanne Ngeow, Huilin Shao, Françoise Thierry, Yuezhen Xue, Wenying Zhang, Declan P. Lunny and David S.P. Tan and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Diana Lim

18 papers receiving 328 citations

Peers

Countries citing papers authored by Diana Lim

Since Specialization

Citations

This map shows the geographic impact of Diana Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana Lim more than expected).

Fields of papers citing papers by Diana Lim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diana Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana Lim. The network helps show where Diana Lim may publish in the future.

Co-authorship network of co-authors of Diana Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Diana Lim. A scholar is included among the top collaborators of Diana Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diana Lim. Diana Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Clearer Horizons: The latest advances in clear cell ovarian cancer treatment 2025 ·Cancer Treatment Reviews ·Félix Blanc‐Durand, Natalie Y.L. Ngoi, Diana Lim, Isabelle Ray‐Coquard, David S.P. Tan	2
2	Unveiling the unique identity of clear-cell endometrial cancer (CCEC): A comprehensive comparative analysis with ovarian counterpart and other endometrial subtypes. 2024 ·Journal of Clinical Oncology ·Félix Blanc‐Durand, Natalie Y.L. Ngoi, Étienne Rouleau, Patricia Pautier, Judith Michels, (unknown), Catherine Genestie, (unknown), Diana Lim, (unknown), Alexandra Léary, David S.P. Tan	1
3	Conditional Knockout of Hypoxia-Inducible Factor 1-Alpha in Tumor-Infiltrating Neutrophils Protects against Pancreatic Ductal Adenocarcinoma 2023 ·International Journal of Molecular Sciences ·Je Lin Sieow, Hweixian Leong Penny, Sin Yee Gun, (unknown), Kaibo Duan, Joe Yeong, Angela Pang, Diana Lim, Han Chong Toh, Tony Kiat Hon Lim, Edgar G. Engleman, Olaf Rötzschke, Lai Guan Ng, Jinmiao Chen, Suet‐Mien Tan, Siew Cheng Wong	9
4	Prevalence, exposure and the public knowledge of keloids on four continents 2022 ·Journal of Plastic Reconstructive & Aesthetic Surgery ·(unknown), (unknown), Diana Lim, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	6
5	Nuclear pCHK1 as a potential biomarker of increased sensitivity to ATR inhibition 2022 ·The Journal of Pathology ·Vignesh Sundararajan, Tuan Zea Tan, Diana Lim, Yanfen Peng, Antje M. Wengner, Natalie Y.L. Ngoi, Anand D. Jeyasekharan, David S.P. Tan	3
6	A multicenter phase II randomized trial of durvalumab (D) versus physician’s choice chemotherapy (PCC) in patients (pts) with recurrent ovarian clear cell adenocarcinoma (MOCCA/APGOT-OV2/GCGS-OV3). 2022 ·Journal of Clinical Oncology ·David S.P. Tan, Chel Hun Choi, Natalie Y.L. Ngoi, Haoyang Sun, Valerie Heong, Samuel G.W. Ow, Wen Yee Chay, Hee Seung Kim, (unknown), Geraldine Goss, Jeffrey C. Goh, (unknown), Bee Choo Tai, Diana Lim, Nivashini Kaliaperumal, (unknown), John Connolly, Jae‐Weon Kim, Michael Friedländer, Kidong Kim	17
7	GAGE mediates radio resistance in cervical cancers via the regulation of chromatin accessibility 2021 ·Cell Reports ·Dawn Sijin Nin, (unknown), Tuan Zea Tan, Diana Lim, J Damen, (unknown), Ziyu Dai, Zheng‐Wei Lee, (unknown), Yiat Horng Leong, Sudhakar Jha, Joseph Ng, Jeffrey Low, Shih‐Chung Chang, David S.P. Tan, Wei Wu, Bok Ai Choo, Lih‐Wen Deng	14
8	A multi‐ethnic analysis of immune‐related gene expression signatures in patients with ovarian clear cell carcinoma 2021 ·The Journal of Pathology ·Valerie Heong, Tuan Zea Tan, (unknown), Jieru Ye, Diana Lim, C. Simon Herrington, Yasushi Iida, Mitsutake Yano, Masanori Yasuda, Natalie Y.L. Ngoi, (unknown), Aikou Okamoto, Charlie Gourley, Kosei Hasegawa, David S.P. Tan, Ruby Yun‐Ju Huang	13
9	Whole Exome Sequencing of Multi-Regional Biopsies from Metastatic Lesions to Evaluate Actionable Truncal Mutations Using a Single-Pass Percutaneous Technique 2020 ·Cancers ·Valerie Heong, (unknown), (unknown), (unknown), Tuan Zea Tan, Ross A. Soo, Brendan Pang, Diana Lim, Anil Gopinathan, Samuel G.W. Ow, Cheng Ean Chee, Boon Cher Goh, Soo Chin Lee, Wei Peng Yong, Andrea Li Ann Wong, (unknown), Richie Soong, David S.P. Tan	2
10	Analysis of gene expression signatures identifies prognostic and functionally distinct ovarian clear cell carcinoma subtypes 2019 ·EBioMedicine ·Tuan Zea Tan, Jieru Ye, (unknown), Diana Lim, Natalie Y.L. Ngoi, David S.P. Tan, Ruby Yun‐Ju Huang	41
11	Visual and modular detection of pathogen nucleic acids with enzyme–DNA molecular complexes 2018 ·Nature Communications ·Nicholas R. Y. Ho, (unknown), (unknown), Diana Lim, Tze Ping Loh, Huilin Shao	80
12	Decoding transcriptomic intra‐tumour heterogeneity to guide personalised medicine in ovarian cancer 2018 ·The Journal of Pathology ·Tuan Zea Tan, Valerie Heong, Jieru Ye, Diana Lim, Jeffrey Low, Mahesh Choolani, Clare L. Scott, David S.P. Tan, Ruby Yun‐Ju Huang	11
13	Integrated molecular analysis of Asian ovarian cancer: Gene expression and whole exome sequencing analyses from the iPocc Translational Research study (TriPocc). 2018 ·Journal of Clinical Oncology ·Ruby Yun‐Ju Huang, Tuan Zea Tan, Jieru Ye, Christiane Kuschal, (unknown), (unknown), (unknown), Jia Tay, Mohd Feroz Mohd Omar, Sho Sato, Anand D. Jeyasekharan, Diana Lim, (unknown), Keiichi Fujiwara, Kosei Hasegawa, David S.P. Tan	0
14	Value of a molecular screening program to support clinical trial enrollment in Asian cancer patients: The Integrated Molecular Analysis of Cancer (IMAC) Study 2017 ·International Journal of Cancer ·Valerie Heong, Nicholas Syn, (unknown), Nur Sabrina Sapari, (unknown), (unknown), (unknown), Diana Lim, Brendan Pang, Yee Liang Thian, (unknown), Andrea Li‐Ann Wong, Ross A. Soo, Wei Peng Yong, Cheng Ean Chee, Soo Chin Lee, Boon Cher Goh, Richie Soong, David S.P. Tan	9
15	Evaluation of the methods to identify patients who may benefit from PARP inhibitor use 2016 ·Endocrine Related Cancer ·Diana Lim, Joanne Ngeow	25
16	HPV16-E2 induces prophase arrest and activates the cellular DNA damage response in vitro and in precursor lesions of cervical carcinoma 2015 ·Oncotarget ·Yuezhen Xue, Shen Yon Toh, Pingping He, (unknown), Diana Lim, (unknown), Jean‐Pierre Abastado, Françoise Thierry	7
17	HPV16 E2 Is an Immediate Early Marker of Viral Infection, Preceding E7 Expression in Precursor Structures of Cervical Carcinoma 2010 ·Cancer Research ·Yuezhen Xue, Sophie Bellanger, Wenying Zhang, Diana Lim, Jeffrey Low, Declan P. Lunny, Françoise Thierry	80
18	Phylogenetic Relationships of the Seven Coat Protein Subunits of the Coatomer Complex, and Comparative Sequence Analysis of Murine Xenin and Proxenin 2001 ·Biochemical Genetics ·Vincent Chow, Meena Kishore Sakharkar, Diana Lim, (unknown)	2
19	Postexposure treatment of experimental DHBV infection: A new therapeutic strategy 1990 ·Journal of Medical Virology ·(unknown), (unknown), Karen Vickery, Diana Lim, Yvonne E. Cossart	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact